Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-024355
Filing Date
2017-04-04
Accepted
2017-04-04 08:07:39
Documents
1
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1570
  Complete submission text file 0001209191-17-024355.txt   3146
Mailing Address C/O XENETIC BIOSCIENCES, INC. 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
PARSLOW JAMES F (Reporting) CIK: 0001285943 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37937 | Film No.: 17736214

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations